The Oklahoma Health Care Safety Net and Affordable Prescriptions Accessibility Act aims to enhance access to affordable prescriptions by establishing protections for entities participating in the federal 340B drug discount program. The bill prohibits health insurance issuers, pharmacy benefits managers, and other third-party payors from discriminating against 340B entities in terms of reimbursement rates, terms, and conditions. Specifically, it ensures that 340B entities are reimbursed at rates equal to those for non-340B entities and prevents additional burdens or restrictions that could interfere with patient choice or access to medications. The Attorney General and Insurance Commissioner are given enforcement authority, with penalties for violations ranging from censure to civil fines.

Additionally, the bill restricts manufacturers and distributors from interfering with the acquisition and delivery of 340B drugs to authorized pharmacies. It emphasizes that any rules or regulations established under this act must align with federal law and does not conflict with existing state laws. The act is set to take effect on November 1, 2025, and includes provisions for noncodification and federal preemption.